Synthetic cannabinoid activates anxiety-linked neurons in mice
A Northwestern mouse study points to somatostatin neurons in the central amygdala as a possible mechanism for cannabinoid-related anxiety under stress.

Northwestern University researchers reported Oct. 2 in a peer-reviewed Nature Communications study that a synthetic cannabinoid activated somatostatin neurons in the central amygdala and increased threat-related anxiety behavior in mice.
Evidence grade: Early (small, animal, cell or preprint). The Oct. 6 ScienceDaily summary described an animal mechanism, not a human cannabis trial; that distinction matters as cannabis use and related emergency visits have risen in the U.S., according to the Northwestern material.
Researchers exposed the animals to a fox-urine odor after giving them either placebo or the synthetic cannabinoid. Compared with placebo-treated mice, cannabinoid-treated mice froze more often and spent less time investigating the odor.
"The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis or the situation they are in turns stressful or scary," said Sachin Patel, senior author and chair of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine.
The team monitored mouse brain activity with an implanted microscope and studied brain tissue to examine neuron-to-neuron signaling. The experiments indicated the cannabinoid weakened an inhibitory mechanism that normally restrains somatostatin neurons, leaving those cells more active.
"Higher doses of cannabinoids and environmental stress worked together to synergistically release the 'brake' on the central amygdala, which in turn drove excessive anxiety," Patel said.
When researchers genetically silenced the somatostatin neurons, cannabinoid-treated mice were less likely to avoid the predator odor. Genetic silencing is an experimental laboratory tool, so the result identifies a pathway rather than a treatment.
Cannabinoids are substances that include THC, the main psychoactive ingredient in cannabis. The Northwestern material said U.S. cannabis use and emergency department visits involving adverse drug effects have risen, and cited prior studies reporting an association between cannabis use and higher long-term anxiety risk.
The study cannot show that the same pathway explains anxiety in people. It used mice, a synthetic cannabinoid and a predator-odor stressor, so it cannot determine how different cannabis products, doses or settings affect humans.
The paper, titled "Cannabinoid modulation of central amygdala population dynamics during threat investigation," listed support from the National Institutes of Health and the Brain & Behavior Research Foundation's Young Investigator Awards.
Source: peer-reviewed study, Nature Communications, Oct. 2, 2026; Northwestern University materials via ScienceDaily, Oct. 6, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Very hot coffee and tea show threefold esophageal SCC association
- Nighttime light exposure correlates with small heart changes in 11,000 adults
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

